D-0272-2022 Class III Terminated
FDA drug recall D-0272-2022 was initiated by Dr. Reddy's Laboratories, Inc. on November 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated June 23, 2023). Affected quantity: 2496 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- December 15, 2021
- Initiation Date
- November 12, 2021
- Termination Date
- June 23, 2023
- Voluntary/Mandated
- N/A
- Product Quantity
- 2496 cartons
Product Description
12 HR Allergy & Congestion Relief Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg Antihistamine I Nasal Decongestant, 20 Extended-Release Tablets USP, Distributed By Cardinal Health, Dublin, Ohio 43107, Made in India, NDC 70000-0518-1.
Reason for Recall
Failed dissolution specifications
Distribution Pattern
USA Nationwide.
Code Information
Lot #: AC2103329G, Exp 1/2023